New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- Hamamatsu Photonics
- 360 Foothill Rd.
- Bridgewater NJ, 08807
- UNITED STATES
Hamamatsu has been working with the Photon for more than 50 years. We have established ourselves as the top company of photoelectron conversion technologies in the world. However, we have yet to fully grasp the nature of the Photon and its potential. The more you study, the more you realize how little you know about the Photon and its applications. That is why we continue to move ahead vigorously with basic research and apply what we learn to photonics.